Alemtuzumab induction therapy in kidney transplantation.
University Medicine Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Andrea
A
Berghofen
University Medicine Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Thomas
T
Singer
University Medicine Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Bernd
B
Krüger
University Medicine Mannheim, University of Heidelberg, 68167 Mannheim, Germany. Electronic address: bernhard.kraemer@umm.de.
Bernhard K
BK
Krämer
University Medicine Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Urs
U
Benck
D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000077552:Basiliximab; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000379:methods*; D008297:Male; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000074323:Alemtuzumab; D000077552:Basiliximab